SCHEMBL6177083

SCHEMBL6177083

S=C(Cl)OCC(Cl)(Cl)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6013775 0.77
SCHEMBL3023 0.71
SCHEMBL13132093 0.71
SCHEMBL28182083 0.71 ALDH1A1 (0.34)
SCHEMBL8420894 0.71
SCHEMBL1408772 0.67 ALDH1A1 (0.37)
SCHEMBL8252306 0.67 CHRM2 (0.33)
Clorethate SCHEMBL41346 0.67 CHRM2 (0.39)
SCHEMBL9230930 0.67 ALDH1A1 (0.34)
SCHEMBL19514706 0.66 CHRM2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1200411-B1 PROCESS FOR SYNTHESIS OF HETEROARYL-SUBSTITUTED UREA COMPOUNDS BOEHRINGER INGELHEIM PHARMA (US) 2005-12-14 EP disclosed
US-6894173-B2 Intermediates useful for synthesis of heteroaryl-substituted urea compounds, and processes of making same BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2005-05-17 US disclosed
US-6835832-B2 Catalytic hydrogenation BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2004-12-28 US disclosed
US-6774233-B2 AUTOIMMUNE DISEASE BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2004-08-10 US disclosed
US-6753426-B2 ANTIINFLAMMATORY AGENTS; AUTOIMMUNE DISEASE BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2004-06-22 US disclosed
US-20030181718-A1 A chemical intermediate carbamate compounds BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2003-09-25 US disclosed
US-20030166930-A1 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2003-09-04 US disclosed
US-20030166931-A1 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2003-09-04 US disclosed
US-6583282-B1 Formation of a urea by reacting an aromatic carbamate with a aromatic amine BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2003-06-24 US disclosed
US-20030109703-A1 Polymorph and process for preparing same BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2003-06-12 US disclosed
EP-1200411-A2 NOVEL PROCESS FOR SYNTHESIS OF HETEROARYL-SUBSTITUTED UREA COMPOUNDS BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2002-05-02 EP disclosed
WO-2001004115-A2 NOVEL PROCESS FOR SYNTHESIS OF HETEROARYL-SUBSTITUTED UREA COMPOUNDS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-01-18 WO disclosed
US-4897416-A 5-OXIMINO-13B-CARBONYLTHIOMILBEMYCIN DERIVATIVES CIBA-GEIGY CORPORATION (US) 1990-01-30 US disclosed
US-4859657-A Pesticides CIBA-GEIGY CORPORATION (US) 1989-08-22 US disclosed
US-4003909-A [(1,2,4-Oxadiazol-3-yl)phenyl]carbamic or thiocarbamic acid esters E. R. SQUIBB & SONS, INC. (US) 1977-01-18 US disclosed
US-3978078-A Process for the preparation of ampicillin RHONE-POULENC S.A. (FR) 1976-08-31 US disclosed